Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-serine and Cognitive Remediation in Schizophrenia
NCT02156908Phase 2Completed
- Sponsor
- Nathan S. Kline Institute for Psychiatric Research
- Start
- Aug 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-serine in schizophrenia, sponsored by Nathan S. Kline Institute for Psychiatric Research. Started Aug 2014; status: completed.
02
Drugs
d-serine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02156908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02156908.